Crossmark

Pathophysiology, assessment and treatment of psoriatic dactylitis

Crossref DOI link: https://doi.org/10.1038/s41584-018-0147-9

Published Online: 2019-01-04

Published Print: 2019-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

McGonagle, Dennis

Tan, Ai Lyn https://orcid.org/0000-0002-9158-7243
Watad, Abdulla

Helliwell, Philip
License Information

Text and Data Mining valid from 2019-01-04
More Information

Article History

First Online: 4 January 2019

Competing interests

: D.M. declares that he has received research grants from Abbvie, Celgene, Janssen, Merck, Novartis and Pfizer and has acted as a consultant for or received honoraria from Abbvie, Celgene, Eli Lilly, Janssen, Merck, Novartis, Pfizer and UCB. A.L.T. declares she has acted as a consultant for or received honoraria from Abbvie, Eli Lilly, Janssen, Novartis and Pfizer. P.H. declares that he has received research grants from Abbvie and Janssen and has acted as a consultant for or received honoraria from Abbvie, Amgen, Celgene, Galapagos, Janssen, Novartis, Pfizer and UCB. A.W. declares no competing interests.